Institutional Ownership
Telix Pharmaceutical Ltd
CUSIP 87961M105SPONSORED ADSTLXQ1 2026
13D / 13G Filings
2
Schedule 13D/13G on record
Beneficial Filers
2
Distinct reporting persons
Largest Stake
7.0%
Max % of class reported
Institutional Holders
37
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
2 filings · latest Feb 14, 2025
Top Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Fmr LLC | 564.8K | $5.40M |
| 2 | Portolan Capital Management, LLC | 541.3K | $5.18M |
| 3 | Lazard Asset Management LLC | 289.9K | $2.77M |
| 4 | Portland Investment Counsel Inc. | 266.2K | $2.55M |
| 5 | Private Advisor Group, LLC | 174.4K | $1.67M |
| 6 | Integrated Wealth Concepts LLC | 164.4K | $1.57M |
| 7 | Raiffeisen Bank International AG | 130.0K | $1.16M |
| 8 | Morgan Stanley | 116.4K | $1.11M |
| 9 | Jpmorgan Chase & Co | 57.3K | $513.8K |
| 10 | Mariner, LLC | 43.4K | $415.3K |